-
Entity Governance & Structural Integrity: Rehabwheel Inc. operates under a rigorous corporate governance framework established by its Board of Directors, executive management team, and specialized advisory boards to ensure long-term structural integrity, regulatory transparency, and fiduciary compliance.
-
Executive Leadership Mandate: The corporate operations, milestone delivery, and overall program execution are directed by Founder & CEO Nikita Chizhov, who oversees system integration, resource allocation, and high-level execution strategy.
-
Technical Architecture & Systems Engineering: Advanced engineering domains—including autonomous system architecture, embedded sensing, motor control, and technical validation—are formally commanded by Chief Technology Officer Dr. Stan McClellan.
-
Clinical Oversight & Translational Safety: Translational relevance, clinical oversight, and safety envelope management are directed by Dr. Ori Lotan, ensuring the medical application meets rigorous real-world standards.
-
Clinical Safety & Risk Mitigation: Clinical safety protocols, comprehensive risk mitigation strategies, and deployment feasibility assessments are governed by Medical Advisor Dr. Michael Meier.
-
Research Strategy & Evidence Interpretation: Outcome strategy, scientific validation, and clinical evidence interpretation are led by Principal Investigator and Chief Research Officer Dr. Stephanie Kolakowsky-Hayner.
-
Neurological Rehabilitation Protocols: Formal governance for neurological rehabilitation protocol design, clinical evidence frameworks, patient motor-recovery strategies, and translational therapy oversight is directed by Chief Neurological Rehabilitation Officer Dr. Denise Gobert.
-
Fiscal Administration & Compliance: Fiscal oversight, financial compliance, and institutional resource allocation are managed by Chief Financial Officer Jag Singh.
-
External Coordination & Strategic Translation: External stakeholder coordination, partner alignment, and post-program translation planning are executed by non-technical operations lead Chief Business Development Officer Kristin Yarboro.
-
Comprehensive Risk Mitigation & Execution Framework: The corporate leadership framework completely covers all critical execution risks—spanning technical, clinical, safety, regulatory, and fiscal domains—necessary to successfully deliver an autonomous cardiovascular therapy system through all rigorous milestone decision gates.
-
Indemnification, Voting & Board Protocols: The bylaws establish formal voting thresholds, regular meeting procedures, written consent mechanisms, and standard liability protections for all directors, executive officers, and core technical leads acting in official service to the corporation.
-
Regulatory Compliance & Safety Envelopes: The governance framework embeds strict adherence to medical device safety standards, compliance protocols, and data protection mandates across all development phases to ensure absolute institutional accountability.
-
Intellectual Property Integration & Governance: The bylaws formally align with corporate intellectual property agreements to ensure all core hardware designs, utility patents, and technological innovations remain fully secured, protected, and assigned under Rehabwheel Inc.
-
Board Committee Structures & Oversight Mandates: Establishes specialized internal committees—including audit, compensation, and technical review boards—to maintain rigorous checks and balances across corporate development and financial allocations.
-
Long-Term Shareholder Protection & Capital Management: Defines policies regarding equity distribution, shareholder rights, capitalization tables, and future venture financing protocols to safeguard the long-term growth and stability of Rehabwheel Inc.
